Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
2019 · Blood · 293 citations
https://doi.org/10.1182/blood.2019002220
L
Liqing Tian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
2.4K
Citations
20
h-index
28
i10-index
Liqing Tian is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Cancer Genomics and Diagnostics & CAR-T cell therapy research & Acute Myeloid Leukemia Research. The author has an h-index of 20, co-authored 76 publications.
ORCID: 0000-0001-9921-0603Papers by this author
worksAnalysis and expression of the carotenoid biosynthesis genes from Deinococcus wulumuqiensis R12 in engineered Escherichia coli
2018 · AMB Express · 26 citations
https://doi.org/10.1186/s13568-018-0624-1
The landscape of coding RNA editing events in pediatric cancer
2021 · BMC Cancer · 24 citations
https://doi.org/10.1186/s12885-021-08956-5
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
2024 · Nature Communications · 21 citations
https://doi.org/10.1038/s41467-024-47649-y
GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells
2023 · Cell Reports Medicine · 20 citations
https://doi.org/10.1016/j.xcrm.2023.101297
Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL)
2021 · Scientific Reports · 12 citations
https://doi.org/10.1038/s41598-021-84647-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat